Skip to main content
Top
Published in: BMC Nephrology 1/2014

Open Access 01-12-2014 | Case report

A case of podocytic infolding glomerulopathy with multiple myeloma

Authors: Makoto Harada, Yuji Kamijo, Takashi Ehara, Hisashi Shimojo, Hidekazu Shigematsu, Makoto Higuchi

Published in: BMC Nephrology | Issue 1/2014

Login to get access

Abstract

Background

Podocytic infolding glomerulopathy (PIG) is a recently described condition causing rare pathological changes to the glomeruli, and has attracted considerable attention. PIG is characterized by specific changes to the thickened glomerular basement membrane (GBM), including microspheres, microtubular structures, and podocytic infolding. Only a small number of cases of PIG have been reported. The clinical features and pathogenesis of this condition are still unclear. To elucidate the characteristics of this glomerulopathy, it is necessary to accumulate information from reported cases. We present here the first reported case of PIG with multiple myeloma.

Case presentation

A 79-year-old Japanese man was admitted to his local hospital with proteinuria, hypergammaglobulinemia, hypoalbuminemia, and kidney dysfunction. Laboratory tests revealed monoclonal IgG(λ) M proteins in the serum and Bence-Jones proteins in the urine. Bone marrow aspiration showed monoclonal plasma cell proliferation, indicating a diagnosis of multiple myeloma. Renal biopsy was performed to determine the cause of the proteinuria and kidney dysfunction. Histological examination of the biopsy specimen showed glomeruli with an irregularly thickened GBM and bubble-like structures in the capillary walls. Immunofluorescence staining did not show glomerular deposition of immunoglobulins, light chains, or complement components. Congo red staining did not show amyloid deposition. Electron microscopy showed an irregularly thickened GBM with unusual structures in the glomerular capillary walls including podocytic infolding and microspheres, suggesting PIG. There were no electron-dense deposits in the GBM, while various findings indicating podocyte injury were detected.

Conclusion

We present here the first reported case of PIG in a patient with multiple myeloma. The mechanisms underlying the development of PIG in multiple myeloma are unknown, but may be associated with podocyte injury.
Appendix
Available only for authorised users
Literature
1.
go back to reference Joh K, Taguchi T, Shigematsu H, Kobayashi Y, Sato H, Nishi S, Katafuchi R, Nomura S, Fujigaki Y, Utsunomiya Y, Sugiyama H, Saito T, Makino H: Proposal of podocytic infolding glomerulopathy as a new disease entity: a review of 25 cases from nationwide research in Japan. Clin Exp Nephrol. 2008, 12: 421-431. 10.1007/s10157-008-0104-z.CrossRefPubMed Joh K, Taguchi T, Shigematsu H, Kobayashi Y, Sato H, Nishi S, Katafuchi R, Nomura S, Fujigaki Y, Utsunomiya Y, Sugiyama H, Saito T, Makino H: Proposal of podocytic infolding glomerulopathy as a new disease entity: a review of 25 cases from nationwide research in Japan. Clin Exp Nephrol. 2008, 12: 421-431. 10.1007/s10157-008-0104-z.CrossRefPubMed
2.
go back to reference Nakajima M, Hewitson TD, Mathews DC, Kincaid-Smith P: Localisation of complement components in association with glomerular extracellular particles in various renal diseases. Virchows Arch A Pathol Anat Histopathol. 1991, 419: 267-272. 10.1007/BF01606517.CrossRefPubMed Nakajima M, Hewitson TD, Mathews DC, Kincaid-Smith P: Localisation of complement components in association with glomerular extracellular particles in various renal diseases. Virchows Arch A Pathol Anat Histopathol. 1991, 419: 267-272. 10.1007/BF01606517.CrossRefPubMed
3.
go back to reference Hinglais N, Kazatchkine MD, Bhakdi S, Appay MD, Mandet C, Grossetete J, Bariety J: Immunohistochemical study of the C5b-9 complex of complement in human kidneys. Kidney Int. 1986, 30: 399-410. 10.1038/ki.1986.198.CrossRefPubMed Hinglais N, Kazatchkine MD, Bhakdi S, Appay MD, Mandet C, Grossetete J, Bariety J: Immunohistochemical study of the C5b-9 complex of complement in human kidneys. Kidney Int. 1986, 30: 399-410. 10.1038/ki.1986.198.CrossRefPubMed
4.
go back to reference Fujigaki Y, Muranaka Y, Sakakima M, Ohta I, Sakao Y, Fujikura T, Sun Y, Katafuchi R, Joh K, Hishida A: Analysis of intra-GBM microstructures in a SLE case with glomerulopathy associated with podocytic infolding. Clin Exp Nephrol. 2008, 12: 432-439. 10.1007/s10157-008-0095-9.CrossRefPubMed Fujigaki Y, Muranaka Y, Sakakima M, Ohta I, Sakao Y, Fujikura T, Sun Y, Katafuchi R, Joh K, Hishida A: Analysis of intra-GBM microstructures in a SLE case with glomerulopathy associated with podocytic infolding. Clin Exp Nephrol. 2008, 12: 432-439. 10.1007/s10157-008-0095-9.CrossRefPubMed
5.
go back to reference Zurlo JJ, Schechter GP, Fries LF: Complement abnormalities in multiple myeloma. Am J Med. 1989, 87: 411-420. 10.1016/S0002-9343(89)80824-1.CrossRefPubMed Zurlo JJ, Schechter GP, Fries LF: Complement abnormalities in multiple myeloma. Am J Med. 1989, 87: 411-420. 10.1016/S0002-9343(89)80824-1.CrossRefPubMed
6.
go back to reference Smith JK, Chi DS, Guarderas J, Brown P, Verghese A, Berk SL: Disseminated echovirus infection in a patient with multiple myeloma and a functional defect in complement. Treatment with intravenous immunoglobulin. Arch Intern Med. 1989, 149: 1455-1457. 10.1001/archinte.1989.00390060159039.CrossRefPubMed Smith JK, Chi DS, Guarderas J, Brown P, Verghese A, Berk SL: Disseminated echovirus infection in a patient with multiple myeloma and a functional defect in complement. Treatment with intravenous immunoglobulin. Arch Intern Med. 1989, 149: 1455-1457. 10.1001/archinte.1989.00390060159039.CrossRefPubMed
7.
go back to reference Skliris A, Happonen KE, Terpos E, Labropoulou V, Børset M, Heinegård D, Blom AM, Theocharis AD: Serglycin inhibits the classical and lectin pathways of complement via its glycosaminoglycan chains: implications for multiple myeloma. Eur J Immunol. 2011, 41: 437-449. 10.1002/eji.201040429.CrossRefPubMed Skliris A, Happonen KE, Terpos E, Labropoulou V, Børset M, Heinegård D, Blom AM, Theocharis AD: Serglycin inhibits the classical and lectin pathways of complement via its glycosaminoglycan chains: implications for multiple myeloma. Eur J Immunol. 2011, 41: 437-449. 10.1002/eji.201040429.CrossRefPubMed
8.
go back to reference Aoyama T, Yamano S, Waxman DJ, Lapenson DP, Meyer UA, Fischer V, Tyndale R, Inaba T, Kalow W, Gelboin HV, Gonzalez FJ: Cytochrome P-450 hPCN3, a novel cytochrome P-450 IIIA gene product that is differentially expressed in adult human liver. cDNA and deduced amino acid sequence and distinct specificities of cDNA-expressed hPCN1 and hPCN3 for the metabolism of steroid hormones and cyclosporine. J Biol Chem. 1989, 264: 10388-10395.PubMed Aoyama T, Yamano S, Waxman DJ, Lapenson DP, Meyer UA, Fischer V, Tyndale R, Inaba T, Kalow W, Gelboin HV, Gonzalez FJ: Cytochrome P-450 hPCN3, a novel cytochrome P-450 IIIA gene product that is differentially expressed in adult human liver. cDNA and deduced amino acid sequence and distinct specificities of cDNA-expressed hPCN1 and hPCN3 for the metabolism of steroid hormones and cyclosporine. J Biol Chem. 1989, 264: 10388-10395.PubMed
9.
go back to reference Lugassy G, Platok I, Schlesinger M: Hypocomplementemia in multiple myeloma. Leuk Lymphoma. 1999, 33: 365-370.CrossRefPubMed Lugassy G, Platok I, Schlesinger M: Hypocomplementemia in multiple myeloma. Leuk Lymphoma. 1999, 33: 365-370.CrossRefPubMed
10.
go back to reference Matsuo T, Kobayashi Y, Nemoto N, Sano T, Kamata K, Shigematsu H: A nephrotic case of vesicoureteral reflux representing focal segmental glomerulosclerosis associated with podocytic infolding lesions. Clin Exp Nephrol. 2008, 12: 494-500. 10.1007/s10157-008-0086-x.CrossRefPubMed Matsuo T, Kobayashi Y, Nemoto N, Sano T, Kamata K, Shigematsu H: A nephrotic case of vesicoureteral reflux representing focal segmental glomerulosclerosis associated with podocytic infolding lesions. Clin Exp Nephrol. 2008, 12: 494-500. 10.1007/s10157-008-0086-x.CrossRefPubMed
11.
go back to reference Eriguchi M, Oka H, Mizobuchi T, Kamimura T, Sugawara K, Harada A: Long-term outcomes of idiopathic membranous nephropathy in Japanese patients treated with low-dose cyclophosphamide and prednisolone. Nephrol Dial Transplant. 2009, 24: 3082-3088. 10.1093/ndt/gfp251.CrossRefPubMed Eriguchi M, Oka H, Mizobuchi T, Kamimura T, Sugawara K, Harada A: Long-term outcomes of idiopathic membranous nephropathy in Japanese patients treated with low-dose cyclophosphamide and prednisolone. Nephrol Dial Transplant. 2009, 24: 3082-3088. 10.1093/ndt/gfp251.CrossRefPubMed
12.
go back to reference Shiiki H, Saito T, Nishitani Y, Mitarai T, Yorioka N, Yoshimura A, Yokoyama H, Nishi S, Tomino Y, Kurokawa K, Sakai H: Prognosis and risk factors for idiopathic membranous nephropathy with nephrotic syndrome in Japan. Kidney Int. 2004, 65: 1400-1407. 10.1111/j.1523-1755.2004.00518.x.CrossRefPubMed Shiiki H, Saito T, Nishitani Y, Mitarai T, Yorioka N, Yoshimura A, Yokoyama H, Nishi S, Tomino Y, Kurokawa K, Sakai H: Prognosis and risk factors for idiopathic membranous nephropathy with nephrotic syndrome in Japan. Kidney Int. 2004, 65: 1400-1407. 10.1111/j.1523-1755.2004.00518.x.CrossRefPubMed
Metadata
Title
A case of podocytic infolding glomerulopathy with multiple myeloma
Authors
Makoto Harada
Yuji Kamijo
Takashi Ehara
Hisashi Shimojo
Hidekazu Shigematsu
Makoto Higuchi
Publication date
01-12-2014
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2014
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/1471-2369-15-32

Other articles of this Issue 1/2014

BMC Nephrology 1/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.